Vault-13

First Turn Management, LLC

DEL MAR, CA · CIK 1993440 · 13F filing filed 2025-05-15

SEC-registered investment adviser since 2023 · limited liability company

As an employer

$496.1m reported value -11.2% vs Q4 2024
35positions
46.8%in top 10
8 new 12 added 13 reduced 9 sold out vs Q4 2024

Holdings, Q1 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 INSMED INC COM PAR $.01 INSM INSM 401,629 $30.6m6.18% 6.18% ReducedShares held: Q2 2024 323.4k, Q3 2024 356.5k, Q4 2024 447.0k, Q1 2025 401.6k -45.4k -45,351 -10.2%
2 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 435,385 $27.6m5.57% 5.57% ReducedShares held: Q2 2024 0, Q3 2024 572.9k, Q4 2024 641.9k, Q1 2025 435.4k -206.5k -206,516 -32.2%
3 ARGENX SE SPONSORED ADR ARGX ARGX 41,911 $24.8m5.00% 5.00% ReducedShares held: Q2 2024 80.0k, Q3 2024 54.4k, Q4 2024 43.1k, Q1 2025 41.9k -1.2k -1,167 -2.7%
4 NUVALENT INC COM COM 331,927 $23.5m4.75% 4.75% AddedShares held: Q2 2024 252.3k, Q3 2024 359.1k, Q4 2024 309.5k, Q1 2025 331.9k +22.4k +22,406 7.2%
5 XENON PHARMACEUTICALS INC COM XENE XENE 683,451 $22.9m4.62% 4.62% ReducedShares held: Q2 2024 339.9k, Q3 2024 325.2k, Q4 2024 685.0k, Q1 2025 683.5k -1.5k -1,535 -0.2%
6 BRIDGEBIO PHARMA INC COM BBIO BBIO 656,699 $22.7m4.58% 4.58% AddedShares held: Q2 2024 0, Q3 2024 399.8k, Q4 2024 452.3k, Q1 2025 656.7k +204.4k +204,409 45.2%
7 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 503,014 $22.7m4.57% 4.57% ReducedShares held: Q2 2024 703.4k, Q3 2024 647.6k, Q4 2024 506.9k, Q1 2025 503.0k -3.9k -3,894 -0.8%
8 NATERA INC COM NTRA NTRA 139,942 $19.8m3.99% 3.99% AddedShares held: Q2 2024 0, Q3 2024 155.7k, Q4 2024 99.2k, Q1 2025 139.9k +40.8k +40,783 41.1%
9 MERUS N V COM MRUS MRUS 463,960 $19.5m3.94% 3.94% AddedShares held: Q2 2024 321.9k, Q3 2024 308.0k, Q4 2024 285.2k, Q1 2025 464.0k +178.8k +178,801 62.7%
10 BOSTON SCIENTIFIC CORP COM BSX BSX 178,156 $18.0m3.62% 3.62% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 178.2k
11 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 113,278 $17.7m3.56% 3.56% AddedShares held: Q2 2024 186.6k, Q3 2024 150.6k, Q4 2024 87.8k, Q1 2025 113.3k +25.5k +25,474 29.0%
12 TG THERAPEUTICS INC COM TGTX TGTX 400,644 $15.8m3.18% 3.18% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 400.6k
13 VERA THERAPEUTICS INC CL A VERA VERA 623,612 $15.0m3.02% 3.02% AddedShares held: Q2 2024 212.9k, Q3 2024 326.5k, Q4 2024 464.8k, Q1 2025 623.6k +158.8k +158,805 34.2%
14 AXSOME THERAPEUTICS INC COM AXSM AXSM 118,179 $13.8m2.78% 2.78% ReducedShares held: Q2 2024 337.2k, Q3 2024 255.3k, Q4 2024 192.1k, Q1 2025 118.2k -74.0k -73,967 -38.5%
15 GUARDANT HEALTH INC COM GH GH 315,737 $13.5m2.71% 2.71% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 315.7k
16 SPRINGWORKS THERAPEUTICS INC COM SWTX SWTX 304,076 $13.4m2.71% 2.71% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 304.1k
17 GLAUKOS CORP COM GKOS GKOS 136,241 $13.4m2.70% 2.70% AddedShares held: Q2 2024 0, Q3 2024 96.1k, Q4 2024 96.1k, Q1 2025 136.2k +40.1k +40,144 41.8%
18 EXACT SCIENCES CORP COM EXAS EXAS 300,909 $13.0m2.63% 2.63% ReducedShares held: Q2 2024 0, Q3 2024 0, Q4 2024 309.9k, Q1 2025 300.9k -9.0k -8,981 -2.9%
19 INSULET CORP COM PODD PODD 49,350 $13.0m2.61% 2.61% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 49.4k
20 REVOLUTION MEDICINES INC COM RVMD RVMD 340,109 $12.0m2.42% 2.42% ReducedShares held: Q2 2024 329.5k, Q3 2024 0, Q4 2024 403.9k, Q1 2025 340.1k -63.8k -63,806 -15.8%
21 JANUX THERAPEUTICS INC COM JANX JANX 430,163 $11.6m2.34% 2.34% AddedShares held: Q2 2024 0, Q3 2024 0, Q4 2024 383.6k, Q1 2025 430.2k +46.6k +46,561 12.1%
22 ORIC PHARMACEUTICALS INC COM ORIC ORIC 2,027,430 $11.3m2.28% 2.28% AddedShares held: Q2 2024 1.5m, Q3 2024 1.5m, Q4 2024 1.5m, Q1 2025 2.0m +576.4k +576,393 39.7%
23 ADMA BIOLOGICS INC COM ADMA ADMA 566,945 $11.2m2.27% 2.27% ReducedShares held: Q2 2024 0, Q3 2024 665.0k, Q4 2024 684.2k, Q1 2025 566.9k -117.3k -117,285 -17.1%
24 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 22,109 $10.9m2.21% 2.21% ReducedShares held: Q2 2024 41.9k, Q3 2024 30.3k, Q4 2024 35.0k, Q1 2025 22.1k -12.9k -12,923 -36.9%
25 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 535,092 $10.5m2.12% 2.12% UnchangedShares held: Q2 2024 413.2k, Q3 2024 535.1k, Q4 2024 535.1k, Q1 2025 535.1k
26 VAXCYTE INC COM PCVX PCVX 276,905 $10.5m2.11% 2.11% UnchangedShares held: Q2 2024 260.3k, Q3 2024 212.0k, Q4 2024 276.9k, Q1 2025 276.9k
27 APOGEE THERAPEUTICS INC COM COM 229,675 $8.6m1.73% 1.73% ReducedShares held: Q2 2024 318.3k, Q3 2024 0, Q4 2024 252.7k, Q1 2025 229.7k -23.1k -23,050 -9.1%
28 ARS PHARMACEUTICALS INC COM SPRY SPRY 669,010 $8.4m1.70% 1.70% AddedShares held: Q2 2024 0, Q3 2024 593.3k, Q4 2024 593.3k, Q1 2025 669.0k +75.7k +75,719 12.8%
29 BLUEPRINT MEDICINES CORP COM BPMC BPMC 92,033 $8.1m1.64% 1.64% AddedShares held: Q2 2024 184.9k, Q3 2024 178.9k, Q4 2024 67.1k, Q1 2025 92.0k +24.9k +24,890 37.1%
30 RADNET INC COM RDNT RDNT 157,615 $7.8m1.58% 1.58% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 157.6k
31 HEALTHEQUITY INC COM HQY HQY 83,966 $7.4m1.50% 1.50% ReducedShares held: Q2 2024 0, Q3 2024 0, Q4 2024 125.9k, Q1 2025 84.0k -41.9k -41,901 -33.3%
32 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 179,196 $7.0m1.41% 1.41% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 179.2k
33 HARROW INC COM HROW HROW 188,829 $5.0m1.01% 1.01% ReducedShares held: Q2 2024 0, Q3 2024 326.6k, Q4 2024 304.9k, Q1 2025 188.8k -116.0k -116,045 -38.1%
34 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 71,775 $2.7m0.55% 0.55% AddedShares held: Q2 2024 0, Q3 2024 0, Q4 2024 45.5k, Q1 2025 71.8k +26.2k +26,239 57.6%
35 SOLENO THERAPEUTICS INC COM SLNO SLNO 29,115 $2.1m0.42% 0.42% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 29.1k

Sold out since Q4 2024

SecurityTickerShares held beforeValue then
INTRA-CELLULAR THERAPIES INC ITCI ITCI 294,414 $24.6m294.4k shares
CRINETICS PHARMACEUTICALS IN CRNX CRNX 453,376 $23.2m453.4k shares
GERON CORP GERN GERN 3,893,327 $13.8m3.9m shares
DAY ONE BIOPHARMACEUTICALS I 947,878 $12.0m947.9k shares
ARCELLX INC ACLX ACLX 152,356 $11.7m152.4k shares
BIOHAVEN LTD BHVN BHVN 262,442 $9.8m262.4k shares
CORMEDIX INC CRMD CRMD 1,021,421 $8.3m1.0m shares
BICARA THERAPEUTICS INC BCAX BCAX 346,170 $6.0m346.2k shares
SYNDAX PHARMACEUTICALS INC SNDX SNDX 441,587 $5.8m441.6k shares